Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer
Clinical trial NCT07095023 · RECRUITING
Trial details
- NCT number
- NCT07095023
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2026-12-30
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.